EFPIA Newsletter 05 October 2017

#WeWontRest video     Rachelle Doody, Global head of Neurodegeneration, Roche   "#WeWontRest until people with Alzheimer's have treatment options that will give them control and dignity instead of a future of disability" In this video, Rachelle Doody, Global head of Neurodegeneration at Roche, talks about her lifelong mission to find more and better treatment for Alzheimer's disease. Read more →

Statements     05 October 2017 05102017 EFPIA response to BMJ article on efficacy of cancer medicines EFPIA calls for stakeholders to work together to optimise our ability to assess value with the tools already at our... Read more →

Blogs     05 October 2017 05102017 Incentives, IP and Smaller companies: the Story of CureVac With over 7000 medicines in development, new treatments will continue to change patients’ lives; slowing disease progression,... Read more →

Events     25 OCT 2017   11 September 2017 2017 ICHOM Conference Washington, D.C. Join value-innovators from across the health care spectrum in Washington, D.C. Learn more →       21 NOV 2017   19 July 2017 War on Cancer – a patient’s journey The HAC, London, UK 3rd annual conference organised by The Economist Events Learn more →

	27 NOV 2017			14 July 2017 1st European Alliance for Personalised Medicine Congress Belfast, Northern Ireland Personalising Your Health: A Global Imperative! Learn more →

	22 JAN 2018			04102017 SafeSciMET Courses on regulatory requirements and guidelines Lisbon, Portugal A course to provide participants with a comprehensive overview of the required in vitro and in vivo nonclinical studies,... Learn more →

What we are reading Gastein boss: Drugs access is ‘sensitive’ and cannot be viewed in isolation 04 October 2017  (EurActiv) Read more → ADAPTSMART Newsletter 04 October 2017  (ADAPTSMART) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe